Skin Allergy Therapeutics Market by Indication, Route of Administration, Treatment, Distribution Channel

List of Tables

The Skin Allergy Therapeutics Market is projected to reach USD 8.73 billion by 2030 from USD 4.70 billion in 2022, at a CAGR of 8.04% during the forecast period.

Global Skin Allergy Therapeutics Market

KEY MARKET STATISTICS
Base Year Value [2022]	USD 4.70 billion
Estimated Year Value [2023]	USD 5.04 billion
Forecast Year Value [2030]	USD 8.73 billion
CAGR (%)	8.04%

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Skin Allergy Therapeutics Market.

Based on Indication, market is studied across Angioedema, Contact Dermatitis, Eczema, and Urticaria. The Eczema is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Oral and Parenteral. The Parenteral is projected to witness significant market share during forecast period.

Based on Treatment, market is studied across Immunotherapy, Oral Medications, Phototherapy, and Topical Treatments. The Topical Treatments is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Drug Stores and Retail Pharmacies. The Offline is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Skin Allergy Therapeutics Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Skin Allergy Therapeutics Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Skin Allergy Therapeutics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Astellas Pharma International B.V., AstraZeneca PLC, Bausch Health Companies Inc, Bayer AG, DBV Technologies Inc., Dr.Reddy's Laboratories Limited, Eisai Co., Ltd., Eli Lilly and Company, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., HYCOR Biomedical, LLC, Johnson & Johnson Consumer Inc., LEO Pharma A/S, Ligand Pharmaceuticals Incorporated, Lincoln Diagnostics, Inc., Merck KGaA, Omega Diagnostics Group PLC, Pfizer Inc., Piramal Enterprises Limited, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Synnat Pharma Private Limited, Teva Pharmaceutical Industries Ltd., and Viatris Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Skin Allergy Therapeutics Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Skin Allergy Therapeutics Market?

3. What is the competitive strategic window for identifying opportunities in the Skin Allergy Therapeutics Market?

4. What are the latest technology trends and regulatory frameworks in the Skin Allergy Therapeutics Market?

5. What is the market share of the leading vendors in the Skin Allergy Therapeutics Market?

6. Which modes and strategic moves are suitable for entering the Skin Allergy Therapeutics Market?

Product Code: MRR-521BAA36ED83

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Skin Allergy Therapeutics Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of skin allergy conditions among population
  - 5.1.1.2. Growing awareness of skincare and detection of skin allergies
- 5.1.2. Restraints
  - 5.1.2.1. High costs associated with skincare treatments
- 5.1.3. Opportunities
  - 5.1.3.1. Robust research activities to develop novel skin allergy therapeutics
  - 5.1.3.2. Improved healthcare infrastructure and medical spendings
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulatory requirements for therapeutics development
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Skin Allergy Therapeutics Market, by Indication

6.1. Introduction
6.2. Angioedema
6.3. Contact Dermatitis
6.4. Eczema
6.5. Urticaria

7. Skin Allergy Therapeutics Market, by Route of Administration

7.1. Introduction
7.2. Oral
7.3. Parenteral

8. Skin Allergy Therapeutics Market, by Treatment

8.1. Introduction
8.2. Immunotherapy
8.3. Oral Medications
8.4. Phototherapy
8.5. Topical Treatments

9. Skin Allergy Therapeutics Market, by Distribution Channel

9.1. Introduction
9.2. Offline
- 9.3.1. Drug Stores
- 9.3.2. Retail Pharmacies
9.3. Online

10. Americas Skin Allergy Therapeutics Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Skin Allergy Therapeutics Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Skin Allergy Therapeutics Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. ALK-Abello A/S
- 14.1.2. Astellas Pharma International B.V.
- 14.1.3. AstraZeneca PLC
- 14.1.4. Bausch Health Companies Inc
- 14.1.5. Bayer AG
- 14.1.6. DBV Technologies Inc.
- 14.1.7. Dr.Reddy's Laboratories Limited
- 14.1.8. Eisai Co., Ltd.
- 14.1.9. Eli Lilly and Company
- 14.1.10. GlaxoSmithKline PLC
- 14.1.11. Glenmark Pharmaceuticals Ltd.
- 14.1.12. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
- 14.1.13. HYCOR Biomedical, LLC
- 14.1.14. Johnson & Johnson Consumer Inc.
- 14.1.15. LEO Pharma A/S
- 14.1.16. Ligand Pharmaceuticals Incorporated
- 14.1.17. Lincoln Diagnostics, Inc.
- 14.1.18. Merck KGaA
- 14.1.19. Omega Diagnostics Group PLC
- 14.1.20. Pfizer Inc.
- 14.1.21. Piramal Enterprises Limited
- 14.1.22. Sanofi S.A.
- 14.1.23. Sun Pharmaceutical Industries Ltd.
- 14.1.24. Synnat Pharma Private Limited
- 14.1.25. Teva Pharmaceutical Industries Ltd.
- 14.1.26. Viatris Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing